Saliva as a tool for oral cancer diagnosis and prognosis

Oral Oncology

Volumn 45, Issue 12, 2009, Pages 1006-1010

  Nagler, Rafael M ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Biomarkers; Head and neck cancer; Oral cancer; Saliva; Screening; Tumor markers

Indexed keywords

DNA; GENOMIC DNA; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER PATIENT; DNA METHYLATION; HETEROZYGOSITY LOSS; HUMAN; MOUTH CANCER; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SALIVA ANALYSIS;

HUMANS; METHYLATION; MOUTH NEOPLASMS; OXIDATIVE STRESS; PROGNOSIS; SALIVA; TUMOR MARKERS, BIOLOGICAL;

EID: 70449708959     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.07.005     Document Type: Review

References (67)

1. Pickering V., Jordan R.C., and Schmidt B.L. Elevated salivary endothelin levels in oral cancer patients - a pilot study. Oral Oncol 43 (2007) 37-41
2. Saracoglu U., Guven O., and Durak I. Adenosine deaminase and 5′-nucleotidase activities in saliva from patients with oral and laryngeal cancer. Oral Dis 11 (2005) 323-325
3. Zhong L.P., Chen G.F., Xu Z.F., Zhang X., Ping F.Y., and Zhao S.F. Detection of telomerase activity in saliva from oral squamous cell carcinoma patients. Int J Oral Maxillofac Surg 34 (2005) 566-570
4. Franzmann E.J., Reategui E.P., Carraway K.L., Hamilton K.L., Weed D.T., and Goodwin W.J. Salivary soluble CD44: a potential molecular marker for head and neck cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 735-739
5. Rhodus N.L., Ho V., Miller C.S., Myers S., and Ondrey F. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev 29 (2005) 42-45
6. Rhodus N.L., Ho V., Miller C.S., Myers S., and Ondrey F. A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol 114 (2005) 278-283
7. St John M.A., Li Y., Zhou X., Denny P., Ho C.M., Montemagno C., et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130 (2004) 929-935
8. Kim M.M., Clinger J.D., Masayesva B.G., Ha P.K., Zahurak M.L., Westra W.H., et al. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clin Cancer Res 10 (2004) 8512-8515
9. Dowling P., Wormald R., Meleady P., Henry M., Curran A., and Clynes M. Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis. J Proteomics 71 (2008) 168-175
10. Vairaktaris E., Yapijakis C., Serefoglou Z., Avgoustidis D., Critselis E., Spyridonidou S., et al. Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma. J Cancer Res Clin Oncol 134 (2008) 821-832
11. Franzmann E.J., Reategui E.P., Pedroso F., Pernas F.G., Karakullukcu B.M., Carraway K.L., et al. Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 16 (2007) 1348-1355
12. Zhong L.P., Zhang C.P., Zheng J.W., Li J., Chen W.T., and Zhang Z.Y. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients. Arch Oral Biol 52 (2007) 1079-1087
13. Viet C.T., and Schmidt B.L. Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients. Cancer Epidemiol Biomarkers Prev 17 (2008) 3603-3611
14. Carvalho A.L., Jeronimo C., Kim M.M., Henrique R., Zhang Z., Hoque M.O., et al. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res 14 (2008) 97-107
15. Righini C.A., de Fraipont F., Timsit J.F., Faure C., Brambilla E., Reyt E., et al. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res 13 (2007) 1179-1185
16. Kantola S., Parikka M., Jokinen K., Hyrynkangs K., Soini Y., Alho O.P., et al. Prognostic factors in tongue cancer - relative importance of demographic, clinical and histopathological factors. Br J Cancer 83 (2000) 614-619
17. Myers J.N., Elkins T., Roberts D., and Byers R.M. Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 122 (2000) 44-51
18. Alho O.P., Kantola S., Pirkola U., Laara E., Jokinen K., and Pukkala E. Cancer of the mobile tongue in Finland - increasing incidence, but improved survival. Acta Oncol 38 (1999) 1021-1024
19. Esser D., Anke S., Roessner A., and Freigang B. Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings. Laryngorhinootologie 79 (2000) 478-482
20. Nagler R.M., Braun J., Daitzman M., and Laufer D. Spiral CT angiography - an alternative vascular evaluation technique for head and neck microvascular reconstruction: a preliminary experience. Plast Reconst Surg 100 (1997) 1697-1703
21. Hinerman R.W., Mendenhall W.M., Morris C.G., Amdur R.J., Werning J.W., and Villaret D.B. Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck 26 (2004) 984-994
22. Yeole B.B., Sankaranarayanan R., Sunny M.L., Swaminathan R., and Parkin D.M. Survival from head and neck cancer in Mumbai (Bombay), India. Cancer 89 (2000) 437-444
23. Ribeiro K.C., Kowalski L.P., and Latorre M.R. Impact of comorbidity, symptoms, and patients' characteristics on the prognosis of oral carcinomas. Arch Otolaryngol Head Neck Surg 126 (2000) 1079-1085
24. Sparano A., Weinstein G., Chalian A., Yodul M., and Weber R. Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg 131 (2004) 472-476
25. Yuen P.W., Lam K.Y., Chan A.C., Wei W.I., and Lam L.K. Clinicopathological analysis of local spread of carcinoma of the tongue. Am J Surg 175 (1998) 242-244
26. Muir C., and Weiland L. Upper aerodigestive tract cancers. Cancer 75 (1995) 147-153
27. Nagler R.M., Barak M., Ben-Aryeh H., Peled M., Filatov M., and Laufer D. Early diagnostic and treatment monitoring role of Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer 35 (1999) 1018-1025
28. Bhatavdekar J.M., Patel D.D., Vora H.H., and Balar D.B. Circulating markers and growth factors as prognosticators in men with advanced tongue cancer. Tumour Biol 14 (1993) 55-58
29. Bhatavdekar J.M., Patel D.D., Vora H.H., and Balar D.B. Circulating prolactin and TPS in monitoring the clinical course of male patients with metastatic tongue cancer: a preliminary study. Anticancer Res 13 (1993) 237-240
30. Yen T.C., Lin W.Y., Kao C.H., Cheng K.Y., and Wang S.J. A study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen. Clin Otolaryngol 23 (1998) 82-86
31. Hellner D., Klapdor R., Gundlach K.H., and Schmelze R. Results with the use of the Scc antigen in squamous cell carcinomas of the oral cavity. Dtsch Z Mund Kiefer Gesichtschir 13 (1989) 291-295
32. Zoller J., Fiehn W., Mende U., and Hotz G. The diagnostic value of the tumor markers CEA, "Ca 19-9", "Ca 125", "Ca15-3" and "SCC" for the detection of recurrent tumors in patients with tumors of the head and neck. Dtsch Z Mund Kiefer Gesichtschir 14 (1990) 254-259
33. Zoller J. The value of "tumor markers" in the therapy and aftercare of carcinoma of the oral mucosa. Dtsch Zahn Mund Kieferheilkd Zentralbl 80 (1992) 351-357
34. Kuo W.R., Lee K.W., Ho K.Y., Tsai S.M., Chiang F.Y., and Juan K.H. Tissue polypeptide antigen, carcinoembryonic antigen, carbohydrate antigen, and CA125 levels as tumor markers in squamous cell carcinoma of the head and neck. Kaohsiung J Med Sci 15 (1999) 152-158
35. Krimmel M., Hoffmann J., Krimmel C., Cornelius C.P., and Schwenzer N. Relevance of SCC-Ag, CEA, CA 19.9 and CA 125 for diagnosis and follow-up in oral cancer. J Craniomaxillofac Surg 26 (1998) 243-248
36. Hoffmann J., Munz A., Krimmel M., and Alfter G. Intraoperative and postoperative kinetics of serum tumor markers in patients with oral carcinoma. J Oral Maxillofac Surg 56 (1998) 1390-1393
37. Kurokawa H., Tsuru S., Okada M., Nakamura T., and Kajiyama M. Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity. Int J Oral Maxillofac Surg 22 (1993) 35-38
38. Kurokawa H., Yamashita Y., Tokudome S., and Kajiyama M. Combination assay for tumor markers in oral squamous cell carcinoma. J Oral Maxillofac Surg 55 (1997) 964-966
39. Bigler L.R., Streckfus C.F., Copeland L., Burns R., Dai X., Kuhn M., et al. The potential use of saliva to detect recurrence of disease in women with breast carcinoma. J Oral Pathol Med 31 (2002) 421-431
40. Negri L., Pacchioni D., Calabrese F., Giacomasso S., Mastromatteo V., and Fazio M. Serum and salivary CEA and GICA levels in oral cavity tumours. Int J Biol Markers 3 (1988) 107-112
41. Airoldi M., Negri L., Pedani F., Gerbino G., Camoletto D., and Piantino P. Serum and salivary CEA in benign and malignant lesions of the oral cavity. Boll Soc Ital Biol Sper 60 (1984) 865-870
42. Nagler R., Bahar G., Shpitzer T., and Feinmesser R. Concomitant analysis of salivary tumor markers - a new diagnostic tool for oral cancer. Clin Cancer Res 12 (2006) 3979-3984
43. Bahar G., Feinmesser R., Shpitzer T., Popovtzer A., and Nagler R.M. Salivary analysis in oral cancer patients - DNA and protein oxidation, reactive nitrogen species and antioxidant profile. Cancer 109 (2007) 54-59
44. Almadori G., Bussu F., Galli J., Limongelli A., Persichilli S., Zappacosta B., et al. Salivary glutathione and uric acid levels in patients with head and neck squamous cell carcinoma. Head Neck 29 (2007) 648-654
45. Shpitzer T., Bahar G., Feinmesser R., and Nagler R.M. A comprehensive salivary analysis for oral cancer diagnosis. Cancer Res Clin Oncol 133 (2007) 613-617
46. El-Naggar A.K., Mao L., Staerkel G., Coombes M.M., Tucker S.L., Luna M.A., et al. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn 3 (2001) 164-170
47. Lea I.A., Jackson M.A., Li X., Bailey S., Peddada S.D., and Dunnick J.K. Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns. Carcinogenesis 28 (2007) 1851-1858
48. Zhang L., and Rosin M.P. Loss of heterozygosity: a potential tool in management of oral premalignant lesions?. J Oral Pathol Med 30 (2001) 513-520
49. Viet C.T., Jordan R.C., and Schmidt B.L. DNA promoter hypermethylation in saliva for the early diagnosis of oral cancer. J Calif Dent Assoc 35 (2007) 844-849
50. Righini C.A., de Fraipont F., Reyt E., and Favrot M.C. Aberrant methylation of tumor suppressor genes in head and neck squamous cell carcinoma: is it clinically relevant?. Bull Cancer 94 (2007) 191-197
51. Rosas S.L., Koch W., da Costa Carvalho M.G., Wu L., Califano J., Westra W., et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 61 (2001) 939-942
52. Arellano-Garcia M.E., Hu S., Wang J., Henson B., Zhou H., Chia D., et al. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis 14 (2008) 705-712
53. Hu S., Arellano M., Boontheung P., Wang J., Zhou H., Jiang J., et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 14 (2008) 6246-6252
54. Tan W., Sabet L., Li Y., Yu T., Klokkevold P.R., Wong D.T., et al. Optical protein sensor for detecting cancer markers in saliva. Biosens Bioelectron 24 (2008) 266-271
55. Zimmermann B.G., and Wong D.T. Salivary mRNA targets for cancer diagnostics. Oral Oncol 44 (2008) 425-429
56. Hu S., Yen Y., Ann D., and Wong D.T. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery. Drug Discov Today 12 (2007) 911-916
57. Hu S., Yu T., Xie Y., Yang Y., Li Y., Zhou X., et al. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genom Proteom 4 (2007) 55-64
58. Hu S., Loo J.A., and Wong D.T. Human saliva proteome analysis. Ann NY Acad Sci 1098 (2007) 323-329
59. Zimmermann B.G., Park N.J., and Wong D.T. Genomic targets in saliva. Ann NY Acad Sci 1098 (2007) 184-191
60. Park N.J., Zhou X., Yu T., Brinkman B.M., Zimmermann B.G., Palanisamy V., et al. Characterization of salivary RNA by cDNA library analysis. Arch Oral Biol 52 (2007) 30-35
61. Wong D.T. Salivary diagnostics for oral cancer. J Calif Dent Assoc 34 (2006) 303-308
62. Wong D.T. Towards a simple, saliva-based test for the detection of oral cancer 'oral fluid (saliva), which is the mirror of the body, is a perfect medium to be explored for health and disease surveillance'. Expert Rev Mol Diagn 6 (2006) 267-272
63. Park N.J., Li Y., Yu T., Brinkman B.M., and Wong D.T. Characterization of RNA in saliva. Clin Chem 52 (2006) 988-994
64. Wong D.T. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc 137 (2006) 313-321
65. Brinkman B.M., and Wong D.T. Disease mechanism and biomarkers of oral squamous cell carcinoma. Curr Opin Oncol 18 (2006) 228-233
66. Yang C.Y., Brooks E., Li Y., Denny P., Ho C.M., Qi F., et al. Detection of picomolar levels of interleukin-8 in human saliva by SPR. Lab Chip 5 (2005) 1017-1023
67. Li Y., St John M.A., Zhou X., Kim Y., Sinha U., Jordan R.C., et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10 (2004) 8442-8450